Showing 1 - 4 results of 4 for search 'Pu-Gen An', query time: 0.02s
Refine Results
-
1
Tislelizumab plus nimotuzumab is effective against recurrent or metastatic oral squamous cell carcinoma among patients with a performance status score ≥ 2: a retrospective study by Wen-Jie Wu, Wen-Jie Wu, Wen-Jie Wu, Pu-Gen An, Pu-Gen An, Pu-Gen An, Yi-Wei Zhong, Yi-Wei Zhong, Yi-Wei Zhong, Xiao Hu, Xiao Hu, Xiao Hu, Lin Wang, Lin Wang, Lin Wang, Jie Zhang, Jie Zhang, Jie Zhang
Published 2024-01-01
Article -
2
Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: a real−world retrospective study by Wen-Jie Wu, Wen-Jie Wu, Wen-Jie Wu, Qian Liu, Qian Liu, Qian Liu, Pu-Gen An, Pu-Gen An, Pu-Gen An, Lin Wang, Lin Wang, Lin Wang, Jian-Yun Zhang, Jian-Yun Zhang, Jian-Yun Zhang, Yan Chen, Yan Chen, Yan Chen, Tong Zhang, Jie Zhang, Jie Zhang, Jie Zhang
Published 2023-11-01
Article -
3
Corrigendum: Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: a real−world retrospective study by Wen-Jie Wu, Wen-Jie Wu, Wen-Jie Wu, Qian Liu, Qian Liu, Qian Liu, Pu-Gen An, Pu-Gen An, Pu-Gen An, Lin Wang, Lin Wang, Lin Wang, Jian-Yun Zhang, Jian-Yun Zhang, Jian-Yun Zhang, Yan Chen, Yan Chen, Yan Chen, Tong Zhang, Jie Zhang, Jie Zhang, Jie Zhang
Published 2024-01-01
Article -
4
Transcriptomic insights into adenoid cystic carcinoma via RNA sequencing by Yu-Fang Tang, Yu-Fang Tang, Yu-Fang Tang, Yu-Fang Tang, Pu-Gen An, Pu-Gen An, Pu-Gen An, Bao-Xin Gu, Bao-Xin Gu, Bao-Xin Gu, Shu Yi, Shu Yi, Shu Yi, Xiao Hu, Xiao Hu, Xiao Hu, Wen-Jie Wu, Wen-Jie Wu, Wen-Jie Wu, Jie Zhang, Jie Zhang, Jie Zhang
Published 2023-04-01
Article